UnknownPhase 3

Peripheral Parenteral Nutrition vs Conventional Fluid in Colorectal Resection in ERAS

Spain200 participantsStarted 2016-10

Plain-language summary

Assess if administration of early nutrition support with Perioperative Peripheral Nutrition (PeriOliclimonel) N4-E) in patients undergoing colon cancer resection in an Enhanced Recovery After Surgery (ERAS) Protocol improve the results of morbi-mortality and hospitalization versus standard intravenous fluid therapy.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * scheduled colorectal cancer surgery * ASA I-IV Exclusion Criteria: * Emergency surgery * Distant metastasis * Patient´s refusal to participate * Allergy or hypersensitivity to egg or soy protein * Advanced kidney or hepatic impairment * Severe bleeding disorders * Congenital abnormalities of amino acid metabolism * Hyperlipidemia and severe or difficult to control hyperglycemia

What they're measuring

morbi-mortality

Timeframe: 30 days

Trial details

NCT IDNCT03606863

SponsorAntonio Arroyo Sebastian

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2018-01

Contact for this trial

Antonio Arroyo, MD

966 616 000 arroyocir@hotmail.com

View on ClinicalTrials.gov More Colon Cancer trials